Recurrence of thymoma: clinicopathological features, therapy, and prognosis. 1985

Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima

Factors influencing the recurrence or persistence of thymoma after therapy were investigated in 127 patients with thymoma, including 75 with thymoma and myasthenia gravis. The rate of recurrence or persistence was 19% (24 of 127 patients) overall, 11% (8 of 75 patients) in myasthenic thymoma, and 31% (16 of 52 patients) in nonmyasthenic thymoma. The more advanced the clinical stage, the higher the rate of recurrence or persistence. The recurrence/persistence rate for patients with the same clinical stage was higher in those with nonmyasthenic thymoma (8% in Stage I, 11% in Stage II, 36% in Stage III, and 75% in Stage IV) than in those with myasthenic thymoma (0 in Stage I, 13% in Stage II, 18% in Stage III, and 20% in Stage IV). The prognosis for patients having subtotal resection of tumor was good in myasthenic thymoma (recurrence/persistence rate, 17%) in contrast with nonmyasthenic thymoma (recurrence/persistence rate, 78%). These results suggest that nonmyasthenic thymoma is more malignant than myasthenic thymoma. Postoperative radiotherapy was effective in preventing the recurrence or persistence of thymoma after therapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima
November 2001, Journal of surgical oncology,
Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima
September 1980, The Japanese journal of surgery,
Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima
December 2023, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima
February 2013, Chinese medical journal,
Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima
October 2017, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia,
Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima
January 2014, International journal of clinical and experimental pathology,
Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima
October 1988, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima
May 2021, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima
March 2009, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery,
Y Monden, and K Nakahara, and S Iioka, and S Nanjo, and K Ohno, and Y Fujii, and J Hashimoto, and Y Kitagawa, and A Masaoka, and Y Kawashima
April 2004, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Copied contents to your clipboard!